Interpretation of effect estimates in competing risks survival models: A simulated analysis of organ-specific progression-free survival in a randomised phase III cancer trial
A presentation encouraging the reporting of all competing risk estimated hazard ratios to provide a more complete picture of the treatment effect on patients
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
2016
|